{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T07:20:47Z","timestamp":1766647247417,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.oret.2022.08.023","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T03:00:18Z","timestamp":1662087618000},"page":"261-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of Proton Pump Inhibitor\/Histamine-2 Blocker Use and Ocular Toxoplasmosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Christopher D.","family":"Conrady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejus","family":"Pradeep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"VanderBeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2022.08.023_bib1","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/605433","article-title":"Risk factors for Toxoplasma gondii infection in the United States","volume":"49","author":"Jones","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.oret.2022.08.023_bib2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis","volume":"39","author":"Pappas","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.oret.2022.08.023_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ajo.2003.09.040","article-title":"Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease","volume":"136","author":"Holland","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.08.023_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9394(88)90697-6","article-title":"Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome","volume":"106","author":"Holland","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.08.023_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/09273948.2020.1854316","article-title":"Ocular toxoplasmosis after exposure to wild game","volume":"30","author":"Conrady","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oret.2022.08.023_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","article-title":"Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011","volume":"176","author":"Qato","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.oret.2022.08.023_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/2042098618809927","article-title":"The risks of long-term use of proton pump inhibitors: a critical review","volume":"10","author":"Jaynes","year":"2019","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.oret.2022.08.023_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/pds.3953","article-title":"Identification of smoking using Medicare data--a validation study of claims-based algorithms","volume":"25","author":"Desai","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.oret.2022.08.023_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s10393-016-1198-5","article-title":"Prevalence and risk factors for toxoplasmosis in Middle Java, Indonesia","volume":"14","author":"Retmanasari","year":"2017","journal-title":"Ecohealth"},{"key":"10.1016\/j.oret.2022.08.023_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211627","article-title":"Toxoplasmic retinochoroiditis: the influence of age, number of retinochoroidal lesions and genetic polymorphism for IFN-\u03b3\u00a0+874 T\/A as risk factors for recurrence in a survival analysis","volume":"14","author":"Aleixo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2022.08.023_bib11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/bjo.2008.155861","article-title":"Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral centre in Colombia","volume":"93","author":"de-la-Torre","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2022.08.023_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0161-6420(97)30362-5","article-title":"Atypical, severe toxoplasmic retinochoroiditis in elderly patients","volume":"104","author":"Johnson","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.08.023_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/322800","article-title":"Unusual abundance of atypical strains associated with human ocular toxoplasmosis","volume":"184","author":"Grigg","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.oret.2022.08.023_bib14","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1053\/j.gastro.2008.03.006","article-title":"Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers","volume":"134","author":"Laine","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.oret.2022.08.023_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/08923970009016425","article-title":"Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in\u00a0vitro","volume":"22","author":"Agastya","year":"2000","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.oret.2022.08.023_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vetpar.2016.12.010","article-title":"Survival of Toxoplasma gondii tachyzoites in simulated gastric fluid and cow\u2019s milk","volume":"233","author":"Koethe","year":"2017","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.oret.2022.08.023_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/315416a0","article-title":"Phagosome acidification blocked by intracellular Toxoplasma gondii","volume":"315","author":"Sibley","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.oret.2022.08.023_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.2200126","article-title":"Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts","volume":"249","author":"Joiner","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.oret.2022.08.023_bib19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3201\/eid1206.060025","article-title":"Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil","volume":"12","author":"Khan","year":"2006","journal-title":"Emerg Infect Dis"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022004304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022004304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:31:20Z","timestamp":1762853480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653022004304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2468653022004304"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2022.08.023","relation":{},"ISSN":["2468-6530"],"issn-type":[{"type":"print","value":"2468-6530"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Proton Pump Inhibitor\/Histamine-2 Blocker Use and Ocular Toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2022.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}